Non-depleting anti-CD4 therapy has been shown to suppress autoimmunity and graft rejection by modulating the function of CD4+ T cells by blocking T cell activation and promoting Treg differentiation and suppressor functions (171). This evidence concerns the gene CD4 and Autoimmunity.